Patents by Inventor Da Won KIM

Da Won KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230257812
    Abstract: The present invention relates to a method for determining whether a biological sample of unknown origin is derived from liver tissue and a composition comprising a liver tissue-specific DNA methylation marker for performing the same, and the liver tissue-specific DNA methylation marker has a low methylation level in other tissue except for liver tissue and has a high methylation level in normal liver tissue and liver cancer tissue, and thus, it can determine whether a biological sample is derived from liver tissue with excellent accuracy.
    Type: Application
    Filed: September 29, 2020
    Publication date: August 17, 2023
    Inventors: Young Joon KIM, Da Won KIM, Jeong Sil HA
  • Publication number: 20230109129
    Abstract: The present invention relates to a DNA methylation marker for predicting the recurrence of liver cancer by using the difference in the DNA methylation levels according to a liver cancer prognosis, and when the marker is used, the recurrence of liver cancer can be easily predicted, and a more personalized treatment for patients at high risk of liver cancer recurrence can be provided and clinical information for avoiding unnecessary over-treatment can be provided.
    Type: Application
    Filed: February 26, 2020
    Publication date: April 6, 2023
    Inventors: Young Joon KIM, Da Won KIM, Tae You KIM, Kwang Woong LEE, Jeong Sil HA
  • Publication number: 20220259676
    Abstract: The present invention relates to a method for assessing the prognosis or risk stratification of liver cancer by using a clinical specimen mixed with a normal tissue, wherein at least one CpG site that shows a low methylation level in normal and blood tissues but a high methylation level in only a cancer tissue is measured for methylation level.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 18, 2022
    Inventors: Young Joon KIM, Da Won KIM, Won Young CHOI, Jung Woo LEE, Min Hyeok JUNG, Jeong Sil HA, Ji Won KIM, Yeon Su LEE, Jung Ah HWANG, Tae You KIM, Yoo Joo LIM
  • Publication number: 20220228224
    Abstract: The present invention relates to a method for determining whether a biological sample of unknown origin is derived from liver cancer tissue and a composition comprising a liver cancer tissue-specific DNA methylation marker for performing the same, and the liver cancer tissue-specific DNA methylation marker has a low methylation level in normal liver tissue and other tissue, and has a high methylation level only in liver cancer tissue, and thus, it can determine whether a biological sample is derived from liver cancer tissue with excellent accuracy.
    Type: Application
    Filed: April 6, 2022
    Publication date: July 21, 2022
    Inventors: Young Joon KIM, Da Won KIM, Jeong Sil HA, Ji Won KIM
  • Publication number: 20210147943
    Abstract: The present invention relates to a method for assessing the prognosis or risk stratification of liver cancer by using a clinical specimen mixed with a normal tissue, wherein at least one CpG site that shows a low methylation level in normal and blood tissues but a high methylation level in only a cancer tissue is measured for methylation level.
    Type: Application
    Filed: November 19, 2018
    Publication date: May 20, 2021
    Inventors: Young Joon KIM, Da Won KIM, Won Young CHOI, Jung Woo LEE, Min Hyeok JUNG, Jeong Sil HA, Ji Won KIM, Yeon Su LEE, Jung Ah HWANG, Tae You KIM, Yoo Joo LIM